NS Ventures, a venture capital firm based in Stockholm, Sweden, focuses its investments on the technology, mobile, and business services sectors. The firm seeks to invest in early-stage companies within industries such as financial services, software development applications, and entertainment software.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-c (50% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Aspen Neuroscience | Series B | $147.5M | May 2022 |
 Dewpoint Therapeutics | Series C | $150M | Feb 2022 |
Top Co-Investors
Mirae Asset2 shared
ARCH Venture Partners2 shared
SoftBank Vision Fund1 shared
General Catalyst1 shared
Mubadala Ventures1 shared
3E Bioventures Capital1 shared
Leaps by Bayer1 shared
Polaris Venture Partners1 shared
Samsara BioCapital1 shared
Maverick Ventures1 shared
GV (Google Ventures)1 shared
LYFE Capital1 shared
Revelation Partners1 shared
EDBI1 shared
Lifeforce Capital1 shared
OrbiMed1 shared
Frazier Life Sciences1 shared
Alexandria Venture Investments1 shared
Last updated: 21 April 2026